|
|
amine metabolic process
|
GO:0009308 |
44 |
0.660
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.542
|
|
|
|
negative regulation of jak stat cascade
|
GO:0046426 |
4 |
0.502
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.488
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.452
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.413
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.288
|
Human |
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.271
|
Human |
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.258
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.255
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.251
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.251
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.240
|
Human |
|
|
memory
|
GO:0007613 |
3 |
0.223
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.216
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.211
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.207
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.205
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.201
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.200
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.181
|
Human |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.181
|
Human |
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.170
|
Human |
|
|
long term memory
|
GO:0007616 |
2 |
0.169
|
|
|
|
negative regulation of epidermal growth factor activated receptor activity
|
GO:0007175 |
6 |
0.154
|
Human |
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.153
|
Mouse |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.142
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.141
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.139
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
4 |
0.133
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.133
|
Human |
|
|
regulation of jak stat cascade
|
GO:0046425 |
44 |
0.132
|
Mouse |
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.132
|
Human |
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.132
|
Human |
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.128
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.127
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.118
|
|
|
|
growth hormone receptor signaling pathway
|
GO:0060396 |
10 |
0.118
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.118
|
|
|
|
positive regulation of proteasomal protein catabolic process
|
GO:1901800 |
35 |
0.114
|
Human |
|
|
regulation of interleukin 6 mediated signaling pathway
|
GO:0070103 |
3 |
0.111
|
|
|
|
negative regulation of epidermal growth factor receptor signaling pathway
|
GO:0042059 |
11 |
0.110
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.109
|
Human |
|
|
response to hormone
|
GO:0009725 |
175 |
0.109
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.107
|
|
|
|
negative regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042518 |
2 |
0.105
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.103
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.103
|
Human |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.103
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.102
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.102
|
Human |
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.102
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.100
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.098
|
Human |
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.098
|
|
|
|
response to growth hormone
|
GO:0060416 |
11 |
0.098
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.096
|
Mouse |
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.095
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.094
|
|
|
|
negative regulation of peptidyl tyrosine phosphorylation
|
GO:0050732 |
20 |
0.092
|
Human |
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.091
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.091
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
37 |
0.090
|
Human |
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.090
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.087
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.086
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
35 |
0.086
|
Human |
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.084
|
Human |
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.083
|
Human |
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.083
|
|
|
|
protein dephosphorylation
|
GO:0006470 |
81 |
0.082
|
|
|
|
peptidyl tyrosine dephosphorylation
|
GO:0035335 |
36 |
0.082
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.082
|
Human |
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.082
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.081
|
Mouse |
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.080
|
Human |
|
|
actin filament based process
|
GO:0030029 |
224 |
0.079
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.079
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
3 |
0.079
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.077
|
Human |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.076
|
Human |
|
|
cell adhesion
|
GO:0007155 |
325 |
0.076
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.075
|
Human |
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.075
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.075
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.073
|
Mouse |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.073
|
Human |
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.072
|
Mouse |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.071
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.069
|
Human |
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.069
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.069
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.069
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.069
|
Human |
|
|
regeneration
|
GO:0031099 |
4 |
0.068
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.067
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.066
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.066
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.065
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.064
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
4 |
0.061
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.061
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.056
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.055
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.055
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.054
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.054
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.054
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.053
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.053
|
Human |
|
|
branched chain amino acid metabolic process
|
GO:0009081 |
4 |
0.053
|
|
|
|
regulation of hepatocyte growth factor receptor signaling pathway
|
GO:1902202 |
4 |
0.052
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.052
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
2 |
0.051
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.051
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.051
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.051
|
Mouse |
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.050
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.049
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.049
|
|
|
|
regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042516 |
18 |
0.048
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.048
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.048
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.048
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.048
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.047
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.047
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.046
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
4 |
0.046
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.046
|
Human |
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
2 |
0.046
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.045
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.045
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.045
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.045
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.044
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.044
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.044
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.044
|
Human |
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.044
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.043
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
47 |
0.043
|
Human |
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.043
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.043
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.043
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.042
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.042
|
|
|
|
cellular response to growth hormone stimulus
|
GO:0071378 |
10 |
0.042
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.042
|
|
|
|
taurine metabolic process
|
GO:0019530 |
1 |
0.042
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.042
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.042
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.041
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
36 |
0.041
|
Human |
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.041
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.041
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.041
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
7 |
0.041
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.040
|
Mouse |
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.040
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.039
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.039
|
|
|
|
negative regulation of t cell receptor signaling pathway
|
GO:0050860 |
4 |
0.039
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.038
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.038
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.037
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.037
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.037
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.037
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.037
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.036
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.036
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.036
|
|
|
|
head development
|
GO:0060322 |
108 |
0.036
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.036
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.036
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.036
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.036
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.035
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.035
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.035
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.035
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.034
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.034
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.034
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.034
|
|
|
|
interleukin 2 mediated signaling pathway
|
GO:0038110 |
3 |
0.034
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.034
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.034
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.034
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.034
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.033
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.033
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.033
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.033
|
|
|
|
positive regulation of jak stat cascade
|
GO:0046427 |
35 |
0.033
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.033
|
|
|
|
growth
|
GO:0040007 |
202 |
0.033
|
Mouse |
|
|
regulation of tyrosine phosphorylation of stat protein
|
GO:0042509 |
30 |
0.033
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.033
|
|
|
|
decidualization
|
GO:0046697 |
4 |
0.033
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.033
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.033
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.032
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.032
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.032
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.031
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.031
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.031
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.031
|
Human |
|
|
dicarboxylic acid metabolic process
|
GO:0043648 |
29 |
0.031
|
|
|
|
citrate metabolic process
|
GO:0006101 |
2 |
0.031
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.031
|
Mouse |
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.030
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.030
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.030
|
|
|
|
negative regulation of type i interferon mediated signaling pathway
|
GO:0060339 |
4 |
0.030
|
|
|
|
negative regulation of tyrosine phosphorylation of stat protein
|
GO:0042532 |
2 |
0.030
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.029
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.029
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.029
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.029
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.029
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.029
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.029
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.028
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.028
|
Human |
|
|
activation of jak2 kinase activity
|
GO:0042977 |
5 |
0.028
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.028
|
Mouse |
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.028
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.028
|
|
|
|
regulation of neuron death
|
GO:1901214 |
56 |
0.028
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.027
|
Mouse |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.027
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
25 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.027
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.027
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.027
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.026
|
Human |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.026
|
|
|
|
regulation of epidermal growth factor activated receptor activity
|
GO:0007176 |
14 |
0.026
|
Human |
|
|
tyrosine phosphorylation of stat3 protein
|
GO:0042503 |
20 |
0.026
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.026
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.026
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.026
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.026
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.026
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
35 |
0.025
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.025
|
Human |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.025
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
73 |
0.025
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.025
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.025
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.025
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.025
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.025
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.025
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
2 |
0.025
|
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
30 |
0.025
|
Human |
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.025
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.025
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.025
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.024
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
32 |
0.024
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.024
|
|
|
|
chromosome separation
|
GO:0051304 |
23 |
0.024
|
|
|
|
tyrosine phosphorylation of stat protein
|
GO:0007260 |
33 |
0.024
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.024
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.024
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.024
|
|
|
|
system process
|
GO:0003008 |
349 |
0.024
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.023
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.023
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.023
|
|
|
|
receptor internalization
|
GO:0031623 |
43 |
0.023
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.023
|
|
|
|
mating
|
GO:0007618 |
1 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.023
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.023
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.022
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.022
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.022
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.022
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.022
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.022
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.022
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.022
|
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.022
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.022
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.021
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.021
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.021
|
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
27 |
0.021
|
Human |
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.021
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.021
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.021
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.021
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.021
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.021
|
Mouse |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.021
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.021
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.021
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.021
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.021
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.020
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.020
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.020
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.020
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.020
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
18 |
0.020
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.020
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.020
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.020
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.020
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.020
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.020
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.020
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.020
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.020
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.020
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.020
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.020
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.019
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.019
|
Human |
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.019
|
|
|
|
oxaloacetate metabolic process
|
GO:0006107 |
1 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.019
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.019
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.019
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.019
|
|
|
|
negative regulation of macrophage differentiation
|
GO:0045650 |
2 |
0.019
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.019
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.019
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.019
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
39 |
0.019
|
Human |
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.019
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.019
|
Mouse |
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.019
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
44 |
0.019
|
Human |
|
|
prostate gland development
|
GO:0030850 |
3 |
0.019
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.019
|
|
|
|
negative regulation of response to interferon gamma
|
GO:0060331 |
2 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.018
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.018
|
Mouse |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.018
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.018
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.018
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.018
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.018
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.018
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.018
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.018
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.018
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
54 |
0.018
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.018
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.018
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.018
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.018
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.018
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
34 |
0.018
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.018
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.018
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.018
|
|
|
|
brain morphogenesis
|
GO:0048854 |
1 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.018
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.018
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.018
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.018
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.017
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.017
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.017
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
37 |
0.017
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.017
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.017
|
|
|
|
mitotic sister chromatid segregation
|
GO:0000070 |
53 |
0.017
|
|
|
|
tricarboxylic acid metabolic process
|
GO:0072350 |
4 |
0.017
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
42 |
0.017
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.017
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.017
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.017
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.017
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.017
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.017
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
56 |
0.017
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.017
|
|
|
|
regulation of neuron projection regeneration
|
GO:0070570 |
1 |
0.017
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.017
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.016
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.016
|
|
|
|
startle response
|
GO:0001964 |
3 |
0.016
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.016
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.016
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.016
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.016
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.016
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.016
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.016
|
|
|
|
response to interleukin 1
|
GO:0070555 |
47 |
0.016
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.016
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.016
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.016
|
|
|
|
nuclear migration
|
GO:0007097 |
1 |
0.016
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.016
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.016
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.016
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.016
|
|
|
|
ribonucleoprotein complex assembly
|
GO:0022618 |
78 |
0.015
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.015
|
|
|
|
negative regulation of protein tyrosine kinase activity
|
GO:0061099 |
13 |
0.015
|
Human |
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.015
|
|
|
|
regulation of tyrosine phosphorylation of stat1 protein
|
GO:0042510 |
11 |
0.015
|
|
|
|
cartilage development
|
GO:0051216 |
31 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
21 |
0.015
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.015
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.015
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.015
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
47 |
0.015
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.015
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.015
|
|
|
|
rostrocaudal neural tube patterning
|
GO:0021903 |
1 |
0.015
|
|
|
|
sister chromatid segregation
|
GO:0000819 |
54 |
0.015
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.015
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.015
|
|
|
|
neuron remodeling
|
GO:0016322 |
2 |
0.015
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
2 |
0.015
|
|
|
|
cell fate commitment involved in pattern specification
|
GO:0060581 |
1 |
0.015
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.015
|
|
|
|
lung alveolus development
|
GO:0048286 |
4 |
0.015
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.015
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.015
|
|
|
|
negative regulation of interleukin 6 mediated signaling pathway
|
GO:0070104 |
2 |
0.015
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.015
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.015
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.015
|
|
|
|
cellular response to erythropoietin
|
GO:0036018 |
3 |
0.014
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.014
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
74 |
0.014
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.014
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.014
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.014
|
|
